Reuters October 13, 2015 ferghanaadmin Press Release “Venture capitalists plough $1 Billion into Euro Biotech” Related Posts BioWorld Today "European Sector Rallying Cry: Comeback, Consolidation" Mesoblast “Celgene Enters Into Equity Placement and Right of First Refusal Agreement” Chemical Marker Reporter "SCHERING AG; acquired rights for Refludan"